TW200504011A - Process and intermediates for the preparation of pyrrolidine carboxylic acids - Google Patents
Process and intermediates for the preparation of pyrrolidine carboxylic acidsInfo
- Publication number
- TW200504011A TW200504011A TW093110274A TW93110274A TW200504011A TW 200504011 A TW200504011 A TW 200504011A TW 093110274 A TW093110274 A TW 093110274A TW 93110274 A TW93110274 A TW 93110274A TW 200504011 A TW200504011 A TW 200504011A
- Authority
- TW
- Taiwan
- Prior art keywords
- intermediates
- preparation
- carboxylic acids
- pyrrolidine carboxylic
- sexual dysfunction
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- NYCVCXMSZNOGDH-UHFFFAOYSA-N pyrrolidine-1-carboxylic acid Chemical class OC(=O)N1CCCC1 NYCVCXMSZNOGDH-UHFFFAOYSA-N 0.000 title abstract 2
- 102000001796 Melanocortin 4 receptors Human genes 0.000 abstract 2
- 108010021436 Type 4 Melanocortin Receptor Proteins 0.000 abstract 2
- 206010057671 Female sexual dysfunction Diseases 0.000 abstract 1
- 206010057672 Male sexual dysfunction Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46279503P | 2003-04-14 | 2003-04-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200504011A true TW200504011A (en) | 2005-02-01 |
Family
ID=33299992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW093110274A TW200504011A (en) | 2003-04-14 | 2004-04-13 | Process and intermediates for the preparation of pyrrolidine carboxylic acids |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20060199958A1 (zh) |
| EP (1) | EP1615882A2 (zh) |
| JP (1) | JP2006523700A (zh) |
| CN (1) | CN1774419A (zh) |
| AR (1) | AR044510A1 (zh) |
| CA (1) | CA2521487A1 (zh) |
| TW (1) | TW200504011A (zh) |
| WO (1) | WO2004092126A2 (zh) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7649002B2 (en) | 2004-02-04 | 2010-01-19 | Pfizer Inc | (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists |
| WO2006123762A1 (ja) * | 2005-05-16 | 2006-11-23 | Sumitomo Chemical Company, Limited | ピロリジン化合物の製造方法 |
| US8013189B2 (en) | 2007-09-21 | 2011-09-06 | Basf Se | Accelerated amide and ester reductions with amine boranes and additives |
| EP2420487A4 (en) * | 2009-04-14 | 2012-10-17 | Astellas Pharma Inc | A NEW METHOD FOR PRODUCING AN OPTICALLY ACTIVE PYRROLIDINE COMPOUND |
| CN104695023B (zh) * | 2015-02-14 | 2017-02-01 | 河北科技大学 | 一水合四氢吡咯‑2‑羧酸单晶及其制备方法 |
| US10550126B2 (en) | 2015-10-16 | 2020-02-04 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| US11512092B2 (en) | 2015-10-16 | 2022-11-29 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| US11524964B2 (en) | 2015-10-16 | 2022-12-13 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| US11365198B2 (en) | 2015-10-16 | 2022-06-21 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| US11780848B2 (en) | 2015-10-16 | 2023-10-10 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1- carboxamide and solid state forms thereof |
| SG11201802990RA (en) | 2015-10-16 | 2018-05-30 | Abbvie Inc | PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF |
| EP3886854A4 (en) | 2018-11-30 | 2022-07-06 | Nuvation Bio Inc. | PYRROLE AND PYRAZOLE COMPOUNDS AND METHODS OF USE THERE |
| UA127255C2 (uk) | 2019-11-07 | 2023-06-21 | Елджі Кем, Лтд. | Агоністи рецептора меланокортину-4 |
| PE20240366A1 (es) | 2020-10-29 | 2024-03-04 | Lg Chemical Ltd | Forma cristalina iii del compuesto agonista de receptor de melanocortina y metodo de preparacion para la misma |
| PE20240124A1 (es) | 2020-10-29 | 2024-01-22 | Lg Chemical Ltd | Forma cristalina ii del compuesto agonista de receptor de melanocortina y metodo de preparacion para la misma |
| IL302429A (en) | 2020-10-29 | 2023-06-01 | Lg Chemical Ltd | A crystalline structure of a melanocortin receptor agonist and a method for its preparation |
| EP4219472A4 (en) | 2020-10-29 | 2024-03-13 | Lg Chem, Ltd. | CRYSTALLINE FORM I OF A MELANOCORTIN RECEPTOR AGONIST COMPOUND AND METHOD FOR THE PRODUCTION THEREOF |
| CN116419757A (zh) | 2020-10-29 | 2023-07-11 | 株式会社Lg化学 | 无定形黑皮质素-4受体激动剂 |
| US20240043407A1 (en) | 2020-12-22 | 2024-02-08 | Lg Chem, Ltd. | Crystalline form i of melanocortin receptor agonist compound and method for preparing same |
| WO2022139441A1 (ko) | 2020-12-22 | 2022-06-30 | 주식회사 엘지화학 | 무정형의 멜라노코르틴 수용체 작용제 및 이의 제조방법 |
| KR20220090458A (ko) | 2020-12-22 | 2022-06-29 | 주식회사 엘지화학 | 멜라노코르틴 수용체 작용제 화합물의 결정형 ⅲ 및 이의 제조방법 |
| TWI814185B (zh) | 2020-12-22 | 2023-09-01 | 南韓商Ｌｇ化學股份有限公司 | 黑皮質素受體促效劑化合物之晶型ii及其製備方法 |
| CN116888110A (zh) | 2021-02-26 | 2023-10-13 | 株式会社Lg 化学 | 黑皮质素-4受体激动剂 |
| CA3217201A1 (en) | 2021-05-06 | 2022-11-10 | Lg Chem, Ltd. | Crystal form vii of melanocortin receptor agonist compound and method for preparing same |
| WO2022235104A1 (ko) | 2021-05-06 | 2022-11-10 | 주식회사 엘지화학 | 멜라노코르틴 수용체 작용제 화합물의 결정형 v 및 이의 제조방법 |
| US20240239769A1 (en) | 2021-05-07 | 2024-07-18 | Lg Chem, Ltd. | Co-crystal of melanocortin receptor agonist compound and vanillin and method for preparing same |
| CA3217198A1 (en) | 2021-05-07 | 2022-11-10 | Lg Chem, Ltd. | Sulfate crystals of melanocortin receptor agonist compound and method of producing same |
| MX2023013129A (es) | 2021-05-07 | 2023-11-28 | Lg Chemical Ltd | Forma cristalina iv de sales de acidos organicos del compuesto agonista del receptor de melanocortina y metodo de preparacion de este. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7826398A (en) * | 1997-06-17 | 1999-01-04 | Abbott Laboratories | Pyrrolidine carboxylic acid derivatives as endothelin antagonists |
| HUP0303376A3 (en) * | 2001-02-28 | 2007-08-28 | Merck & Co Inc | Acylated piperidine derivatives as melanocortin-4 receptor agonists, and pharmaceutical compositions containing them and use thereof |
| EP1372653B1 (en) * | 2001-02-28 | 2006-10-04 | Merck & Co., Inc. | Acylated piperidine derivatives as melanocortin-4 receptor agonists |
-
2004
- 2004-04-06 AR ARP040101164A patent/AR044510A1/es unknown
- 2004-04-09 CA CA002521487A patent/CA2521487A1/en not_active Abandoned
- 2004-04-09 WO PCT/US2004/011253 patent/WO2004092126A2/en not_active Application Discontinuation
- 2004-04-09 JP JP2006509940A patent/JP2006523700A/ja not_active Withdrawn
- 2004-04-09 CN CNA2004800098822A patent/CN1774419A/zh active Pending
- 2004-04-09 EP EP04750027A patent/EP1615882A2/en not_active Withdrawn
- 2004-04-09 US US10/550,640 patent/US20060199958A1/en not_active Abandoned
- 2004-04-13 TW TW093110274A patent/TW200504011A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20060199958A1 (en) | 2006-09-07 |
| WO2004092126A3 (en) | 2005-01-20 |
| JP2006523700A (ja) | 2006-10-19 |
| AR044510A1 (es) | 2005-09-14 |
| CA2521487A1 (en) | 2004-10-28 |
| CN1774419A (zh) | 2006-05-17 |
| WO2004092126A2 (en) | 2004-10-28 |
| WO2004092126B1 (en) | 2005-03-31 |
| EP1615882A2 (en) | 2006-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200504011A (en) | Process and intermediates for the preparation of pyrrolidine carboxylic acids | |
| HK1098125A1 (en) | Indane acetic acid compounds | |
| WO2006027705A3 (en) | Synthesis of triethylenetetramines | |
| RS20050235A (en) | Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b | |
| PL371582A1 (en) | Difluoromethyl thiazolyl carboxanilides | |
| SG10201811715YA (en) | Intermediates and methods for the synthesis of halichondrin b analogs | |
| IL175253A0 (en) | A process for preparing pyrrole derivatives | |
| TW200633977A (en) | Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives | |
| WO2004014310A3 (en) | Novel processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto | |
| SG144736A1 (en) | Synthesis of temozolomide and analogs | |
| WO2006010620A3 (en) | Olanzapine salts and their conversion to olanzapine free base | |
| MXPA05010882A (es) | Preparacion y purificacion de capsaicina sintetica. | |
| MY136380A (en) | Method for producing tetrahydrofuran | |
| PL1732886T3 (pl) | Odmiany polimorficzne estru tert.-butylowego atorwastatyny i ich zastosowanie jako związków pośrednich do wytwarzania atorwastatyny | |
| SG143062A1 (en) | Synthesis of temozolomide and analogs | |
| TW200505923A (en) | Process to beta-ketoamide intermediates to dipeptidyl peptidase inhibitors | |
| MY140932A (en) | Method for producing phthalic anhydride that conforms to specifications | |
| WO2007010412A3 (en) | Syntheses and preparations of narwedine and related novel compounds | |
| AU2001212914A1 (en) | Friedel-craft process for the preparation of thioxanthones | |
| WO2004037769A3 (en) | Cycloalkylamides and their therapeutic use as antiepileptic and anticonvulsant | |
| SG146645A1 (en) | Process for the synthesis of 6-amino-4-(3-chloro-4fluoro-phenylamino)-7- ethoxy-quinoline-3-carbonitrile | |
| HK1100776A1 (en) | A process for the semisynthesis of deserpidine | |
| PL1670745T3 (pl) | Sposób wytwarzania dinitrotoluenu, w którym jako materiał wyjściowy wykorzystuje się ekstrakty zawierające nitrokrezole | |
| WO2007015259A3 (en) | Method of synthesizing key intermediates for the production of camptothecin derivatives | |
| WO2004078109A3 (en) | PROCESS FOR SYNTHESISING USEFUL INTERMEDIATES FOR THE PREPARATION OF ανβ3 RECEPTOR ANTAGONISTS |